Wrist actigraphy for measuring sleep in intervention studies with Alzheimer's disease patients: Application, usefulness, and challenges

Sleep Medicine Reviews

Volumn 17, Issue 6, 2013, Pages 475-488

  Camargos, Einstein F ^a   Louzada, Fernando M ^b   Nóbrega, Otávio T ^c  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Actigraphy; Alzheimer's disease; Dementia; Intervention studies; Literature review; Sleep disturbance

Indexed keywords

HALOPERIDOL; MELATONIN; QUETIAPINE; TRIAZOLAM;

ACTIMETRY; ALZHEIMER DISEASE; ELECTROSTIMULATION; EXPERIMENTAL DESIGN; HUMAN; INTERVENTION STUDY; LIGHT EXPOSURE; POLYSOMNOGRAPHY; REVIEW; SLEEP DISORDER; SLEEP PARAMETERS; TRANSCUTANEOUS NERVE STIMULATION; WRIST;

ACTIGRAPHY; ALZHEIMER'S DISEASE; DEMENTIA; INTERVENTION STUDIES; LITERATURE REVIEW; SLEEP DISTURBANCE;

ACTIGRAPHY; ALZHEIMER DISEASE; HUMANS; SLEEP DISORDERS; WRIST;

EID: 84887606391     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2013.01.006     Document Type: Review

References (96)

1. Vitiello M.V., Borson S. Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment. CNS Drugs 2001, 15:777-796.
2. Ancoli-Israel S., Klauber M.R., Gillin J.C., Campbell S.S., Hofstetter C.R. Sleep in non-institutionalized Alzheimer's disease patients. Aging (Milano) 1994, 6:451-458.
3. Sullivan S.C., Richards K.C. Predictors of circadian sleep-wake rhythm maintenance in elders with dementia. Aging Ment Health 2004, 8:143-152.
4. Yesavage J.A., Friedman L., Kraemer H.C., Noda A., Wicks D., Bliwise D.L., et al. Afollow-up study of actigraphic measures in home-residing Alzheimer's disease patients. JGeriatr Psychiatry Neurol 1998, 11:7-10.
5. Scherder E., Knol D., van Someren E., Deijen J.B., Binnekade R., Tilders F., et al. Effects of low-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease. Neurorehabil Neural Repair 2003, 17:101-108.
6. Scherder E.J., Van Someren E.J., Swaab D.F. Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity rhythm in midstage Alzheimer's disease. Behav Brain Res 1999, 101:105-107.
7. Van Someren E.J., Scherder E.J., Swaab D.F. Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord 1998, 12:114-118.
8. Nowak L., Davis J. Qualitative analysis of therapeutic light effects on global function in Alzheimer's disease. West J Nurs Res 2011, 33:933-952.
9. Burns A., Allen H., Tomenson B., Duignan D., Byrne J. Bright light therapy for agitation in dementia: a randomized controlled trial. Int Psychogeriatr 2009, 21:711-721.
10. Ancoli-Israel S., Gehrman P., Martin J.L., Shochat T., Marler M., Corey-Bloom J., et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med 2003, 1:22-36.
11. Sloane P.D., Williams C.S., Mitchell C.M., Preisser J.S., Wood W., Barrick A.L., et al. High-intensity environmental light in dementia: effect on sleep and activity. JAm Geriatr Soc 2007, 55:1524-1533.
12. McCurry S.M., Pike K.C., Vitiello M.V., Logsdon R.G., Larson E.B., Teri L. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial. JAm Geriatr Soc 2011, 59:1393-1402.
13. Eggermont L.H., Blankevoort C.G., Scherder E.J. Walking and night-time restlessness in mild-to-moderate dementia: a randomized controlled trial. Age Ageing 2010, 39:746-749.
14. Calkins M., Szmerekovsky J.G., Biddle S. Effect of increased time spent outdoors on individuals with dementia residing in nursing homes. JHous Elder 2007, 21:211-228.
15. Eggermont L.H., Knol D.L., Hol E.M., Swaab D.F., Scherder E.J. Hand motor activity, cognition, mood, and the rest-activity rhythm in dementia: a clustered RCT. Behav Brain Res 2009, 196:271-278.
16. Fetveit A., Bjorvatn B. Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home patients with dementia: a pilot study. Am J Geriatr Psychiatry 2005, 13:420-423.
17. Richards K.C., Beck C., O'Sullivan P.S., Shue V.M. Effect of individualized social activity on sleep in nursing home residents with dementia. JAm Geriatr Soc 2005, 53:1510-1517.
18. McCurry S.M., Gibbons L.E., Logsdon R.G., Vitiello M.V., Teri L. Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. JAm Geriatr Soc 2005, 53:793-802.
19. Dowling G.A., Hubbard E.M., Mastick J., Luxenberg J.S., Burr R.L., Van Someren E.J. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer's disease. Int Psychogeriatr 2005, 17:221-236.
20. Dowling G.A., Mastick J., Hubbard E.M., Luxenberg J.S., Burr R.L. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. Int J Geriatr Psychiatry 2005, 20:738-743.
21. Skjerve A., Holsten F., Aarsland D., Bjorvatn B., Nygaard H.A., Johansen I.M. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia. Psychiatry Clin Neurosci 2004, 58:343-347.
22. Fetveit A., Bjorvatn B. The effects of bright-light therapy on actigraphical measured sleep last for several weeks post-treatment. A study in a nursing home population. JSleep Res 2004, 13:153-158.
23. Fetveit A., Skjerve A., Bjorvatn B. Bright light treatment improves sleep in institutionalised elderly - an open trial. Int J Geriatr Psychiatry 2003, 18:520-526.
24. Gasio P.F., Krauchi K., Cajochen C., Someren E., Amrhein I., Pache M., et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol 2003, 38:207-216.
25. Ancoli-Israel S., Martin J.L., Kripke D.F., Marler M., Klauber M.R. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. JAm Geriatr Soc 2002, 50:282-289.
26. Yamadera H., Ito T., Suzuki H., Asayama K., Ito R., Endo S. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci 2000, 54:352-353.
27. Mishima K., Hishikawa Y., Okawa M. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer's type. Chronobiol Int 1998, 15:647-654.
28. Van Someren E.J., Kessler A., Mirmiran M., Swaab D.F. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997, 41:955-963.
29. Satlin A., Volicer L., Ross V., Herz L., Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am J Psychiatry 1992, 149:1028-1032.
30. Mahlberg R., Walther S., Eichmann U., Tracik F., Kunz D. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study. Arch Gerontol Geriatr 2007, 45:19-26.
31. Savaskan E., Schnitzler C., Schroder C., Cajochen C., Muller-Spahn F., Wirz-Justice A. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine. Int J Neuropsychopharmacol 2006, 9:507-516.
32. Howcroft D.J., Jones R.W. Does modafinil have the potential to improve disrupted sleep patterns in patients with dementia?. Int J Geriatr Psychiatry 2005, 20:492-495.
33. Ito T., Yamadera H., Ito R., Suzuki H., Asayama K., Endo S. Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia. Psychiatry Clin Neurosci 2001, 55:281-282.
34. McCarten J.R., Kovera C., Maddox M.K., Cleary J.P. Triazolam in Alzheimer's disease: pilot study on sleep and memory effects. Pharmacol Biochem Behav 1995, 52:447-452.
35. Tractenberg R.E., Singer C.M., Cummings J.L., Thal L.J. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. JSleep Res 2003, 12:331-337.
36. Ancoli-Israel S., Clopton P., Klauber M.R., Fell R., Mason W. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997, 20:24-27.
37. Yesavage J.A., Friedman L., Ancoli-Israel S., Bliwise D., Singer C., Vitiello M.V., et al. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. JGeriatr Psychiatry Neurol 2003, 16:131-139.
38. Serfaty M., Kennell-Webb S., Warner J., Blizard R., Raven P. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry 2002, 17:1120-1127.
39. Moraes Wdos S., Poyares D.R., Guilleminault C., Ramos L.R., Bertolucci P.H., Tufik S. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Sleep 2006, 29:199-205.
40. Moraes W., Poyares D., Sukys-Claudino L., Guilleminault C., Tufik S. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest 2008, 133:677-683.
41. Cooke J.R., Ancoli-Israel S., Liu L., Loredo J.S., Natarajan L., Palmer B.S., et al. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Med 2009, 10:1101-1106.
42. McCurry S.M., Vitiello M.V., Gibbons L.E., Logsdon R.G., Teri L. Factors associated with caregiver reports of sleep disturbances in persons with dementia. Am J Geriatr Psychiatry 2006, 14:112-120.
43. David R., Zeitzer J., Friedman L., Noda A., O'Hara R., Robert P., et al. Non-pharmacologic management of sleep disturbance in Alzheimer's disease. JNutr Health Aging 2010, 14:203-206.
44. Kotronoulas G., Wengström Y., Kearney N. Sleep and sleep-wake disturbances in care recipient-caregiver dyads in the context of a chronic illness: a critical review of the literature. JPain Symptom Manage 2012 Aug 24, [Epub ahead of print].
45. Ownby R.L., Saeed M., Wohlgemuth W., Capasso R., Acevedo A., Peruyera G., et al. Caregiver reports of sleep problems in non-Hispanic white, Hispanic, and African American patients with Alzheimer dementia. JClin Sleep Med 2010, 6:281-289.
46. Hoekert M., der Lek R.F., Swaab D.F., Kaufer D., Van Someren E.J. Comparison between informant-observed and actigraphic assessments of sleep-wake rhythm disturbances in demented residents of homes for the elderly. Am J Geriatr Psychiatry 2006, 14:104-111.
47. Most E.I., Aboudan S., Scheltens P., Van Someren E.J. Discrepancy between subjective and objective sleep disturbances in early- and moderate-stage Alzheimer disease. Am J Geriatr Psychiatry 2012, 20:460-467.
48. Mulin E., Zeitzer J.M., Friedman L., Le Duff F., Yesavage J., Robert P.H., et al. Relationship between apathy and sleep disturbance in mild and moderate Alzheimer's disease: an actigraphic study. JAlzheimers Dis 2011, 25:85-91.
49. Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev 2011, 15:259-267.
50. Martin J.L., Hakim A.D. Wrist actigraphy. Chest 2011, 139:1514-1527.
51. Stone KL, Ancoli-Israel S. Actigraphy. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 5th ed. Philadelphia, PA: Saunders/Elsevier. 1668-75.
52. Morgenthaler T., Alessi C., Friedman L., Owens J., Kapur V., Boehlecke B., et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 2007, 30:519-529.
53. Asayama K., Yamadera H., Ito T., Suzuki H., Kudo Y., Endo S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. JNippon Med Sch 2003, 70:334-341.
54. Gehrman P.R., Connor D.J., Martin J.L., Shochat T., Corey-Bloom J., Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry 2009, 17:166-169.
55. Mahlberg R., Walther S. Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. ZGerontol Geriatr 2007, 40:178-184.
56. Singer C., Tractenberg R.E., Kaye J., Schafer K., Gamst A., Grundman M., et al. Amulticenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003, 26:893-901.
57. Dowling G.A., Burr R.L., Van Someren E.J., Hubbard E.M., Luxenberg J.S., Mastick J., et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. JAm Geriatr Soc 2008, 56:239-246.
58. Riemersma-van der Lek R.F., Swaab D.F., Twisk J., Hol E.M., Hoogendijk W.J., Van Someren E.J. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAm Med Assoc 2008, 299:2642-2655.
59. Giraudeau B., Ravaud P. Preventing bias in cluster randomised trials. PLoS Med 2009, 6:e1000065.
60. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P.C., Devereaux P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. JClin Epidemiol 2010, 63:e1-37.
61. Petkova E., Teresi J. Some statistical issues in the analyses of data from longitudinal studies of elderly chronic care populations. Psychosom Med 2002, 64:531-547.
62. Kramer J.H., Miller B.L. Alzheimer's disease and its focal variants. Semin Neurol 2000, 20:447-454.
63. Chen Y.-K., Lu J.-Y., Mok V.C.T., Ungvari G.S., Chu W.C.W., Wong K.S., et al. Clinical and radiologic correlates of insomnia symptoms in ischemic stroke patients. Int J Geriatr Psychiatry 2011, 26:451-457.
64. Basseti C.L. Sleep and stroke. Principles and practice of sleep medicine 2011, 993-1015. Saunders/Elsevier, Philadelphia, PA. 5th ed.
65. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
66. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
67. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
68. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. Anew clinical scale for the staging of dementia. Br J Psychiatry 1982, 140:566-572.
69. Perneczky R., Wagenpfeil S., Komossa K., Grimmer T., Diehl J., Kurz A. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry 2006, 14:139-144.
70. Gehrman P., Marler M., Martin J.L., Shochat T., Corey-Bloom J., Ancoli-Israel S. The relationship between dementia severity and rest/activity circadian rhythms. Neuropsychiatr Dis Treat 2005, 1:155-163.
71. Wafford K.A., Ebert B. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat Rev Drug Discov 2008, 7:530-540.
72. Onen F., Onen S.H. Altérations des rythmes du sommeil dans la maladie d'Alzheimer. La Revue de Médecine Interne 2003, 24:165-171.
73. Gelinas I., Gauthier L., McIntyre M., Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 1999, 53:471-481.
74. Rosen W.G., Mohs R.C., Davis K.L. Anew rating scale for Alzheimer's disease. Am J Psychiatry 1984, 141:1356-1364.
75. Rosen W.G., Terry R.D., Fuld P.A., Katzman R., Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980, 7:486-488.
76. Reisberg B., Ferris S.H., de Leon M.J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982, 139:1136-1139.
77. Galasko D., Bennett D., Sano M., Ernesto C., Thomas R., Grundman M., et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997, 11:S33-S39.
78. Reisberg B., Auer S.R., Monteiro I.M. Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int Psychogeriatr 1996, 8:301-308. [discussion 51-4].
79. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44:2308-2314.
80. Markowitz J.S., Gutterman E.M., Lilienfeld S., Papadopoulos G. Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep 2003, 26:602-606.
81. Camargos E.F., Pandolfi M.B., Freitas M.P., Quintas J.L., Lima J.O., Miranda L.C., et al. Trazodone for the treatment of sleep disorders in dementia: an open-label, observational and review study. Arq Neuropsiquiatr 2011, 69:44-49.
82. Alexopoulos G.S., Abrams R.C., Young R.C., Shamoian C.A. Cornell scale for depression in dementia. Biol Psychiatry 1988, 23:271-284.
83. Ancoli-Israel S., Cole R., Alessi C., Chambers M., Moorcroft W., Pollak C.P. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26:342-392.
84. Carvalho-Bos S.S., Riemersma-van der Lek R.F., Waterhouse J., Reilly T., Van Someren E.J. Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry 2007, 15:92-100.
85. Fox N.A., Heneghan C., Gonzalez M., Shouldice R.B., de Chazal P. An evaluation of a non-contact biomotion sensor with actimetry. Conf Proc IEEE Eng Med Biol Soc 2007, 2007:2664-2668.
86. Teicher M.H. Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry 1995, 3:18-35.
87. Van Someren E. Improving actigraphic sleep estimates in insomnia and dementia: how many nights?. JSleep Res 2007, 16:269-275.
88. Rowe M., McCrae C., Campbell J., Horne C., Tiegs T., Lehman B., et al. Actigraphy in older adults: comparison of means and variability of three different aggregates of measurement. Behav Sleep Med 2008, 6:127-145.
89. Vallieres A., Morin C.M. Actigraphy in the assessment of insomnia. Sleep 2003, 26:902-906.
90. Van Someren E.J. Melatonin treatment efficacy: for whom and for what?. Sleep Med 2007, 8:193-195.
91. McCurry S.M., Logsdon R.G., Teri L., Gibbons L.E., Kukull W.A., Bowen J.D., et al. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients. JGeriatr Psychiatry Neurol 1999, 12:53-59.
92. Blackwell T., Ancoli-Israel S., Gehrman P.R., Schneider J.L., Pedula K.L., Stone K.L. Actigraphy scoring reliability in the study of osteoporotic fractures. Sleep 2005, 28:1599-1605.
93. Berger A.M., Wielgus K.K., Young-McCaughan S., Fischer P., Farr L., Lee K.A. Methodological challenges when using actigraphy in research. JPain Symptom Manage 2008, 36:191-199.
94. Littner M., Kushida C.A., Anderson W.M., Bailey D., Berry R.B., Davila D.G., et al. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 2003, 26:337-341.
95. Van Someren E.J. Actigraphic monitoring of movement and rest-activity rhythms in aging, Alzheimer's disease, and Parkinson's disease. IEEE Trans Rehabil Eng 1997, 5:394-398.
96. Maggi S., Langlois J.A., Minicuci N., Grigoletto F., Pavan M., Foley D.J., et al. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes. JAm Geriatr Soc 1998, 46:161-168.